Arvee Laboratories reported audited standalone financial results for Q4 and FY26 ending March 31, 2026, with unmodified audit opinion.
FY26 net profit increased 17.7% to ₹252.63 lakhs despite revenue declining 17.4% to ₹3,151.41 lakhs.
Company showed significant inventory buildup to ₹919.13 lakhs and maintained single chemical business segment reporting.
Board approved results on May 19, 2026, confirming no subsidiaries and compliance with SEBI listing regulations.